Image

Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma

Recruiting
18 years and older
Both
Phase 1/2
  • Simplified (AI rewritten)
  • Technical (Original)

This study is for people with relapsed refractory multiple myeloma (a type of blood cancer) or other plasma cell disorders. It tests a new drug called HDP-101 to see if it is safe and how well it works. The study has two parts: one to find the right dose and another to see how the drug works against cancer. People in the study will have to meet specific health requirements and should have tried other cancer treatments before. Some people cannot join, like those with certain infections or other health issues.

  • The study has two parts, and it may take several weeks or months to complete.
  • Participants will receive HDP-101 as a single treatment and be checked for safety and effectiveness.
  • There are health criteria to join, and some past treatments or health conditions might exclude you.
Print
Study details
    Multiple Myeloma

NCT04879043

Heidelberg Pharma AG

11 July 2024

Contact a study center
Not finding the right Trial?

You can also call our Patient navigators who can help you to find the right trial.

Call now
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.